Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/10286
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDavey, Rachel Aen
dc.contributor.authorTebbutt, Niall Cen
dc.contributor.authorFavaloro, Jenny Men
dc.contributor.authorO'neal, David Nen
dc.contributor.authorRae, Dereken
dc.contributor.authorZajac, Jeffrey Den
dc.contributor.authorBest, James Den
dc.date.accessioned2015-05-15T23:41:38Z
dc.date.available2015-05-15T23:41:38Z
dc.date.issued2006-12-17en
dc.identifier.citationLipids in Health and Disease 2006; 5(): 29en
dc.identifier.govdoc17173705en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/10286en
dc.description.abstractSevere combined hyperlipidaemia has occasionally been associated with infiltration of tissues in addition to arteries and the skin. We report a woman with Type 2 diabetes mellitus (DM) and severe combined hyperlipidaemia who developed retinal lipid infiltration, resulting in blindness. A 61-year-old woman with a 15-year history of Type 2 DM was admitted following a two-week history of progressive visual loss. Examination identified lipid infiltration into the retina. Phenotypically she had severe combined hyperlipidaemia with elevated IDL cholesterol and a broad beta band on lipoprotein electrophoresis, raising the possibility of familial dysbetalipoproteinaemia. However, gene sequencing analysis indicated that the patient was homozygous for the E3/E3 allele of the ApoE gene with no mutations detected in either the coding region or intron-exon boundaries. Her lipid profile improved following dietary therapy and gemfibrozil treatment, but this had little effect on either her fundal appearances or her visual acuity. Type 2 DM plays a vital role both in allowing expression of severe combined hyperlipoproteinaemia, in addition to serving as a risk factor for complications such as tissue infiltration.en
dc.language.isoenen
dc.subject.otherAgeden
dc.subject.otherDiabetes Mellitus, Type 2.blood.complications.metabolismen
dc.subject.otherFemaleen
dc.subject.otherHemorrhageen
dc.subject.otherHumansen
dc.subject.otherHyperlipidemias.blood.complications.metabolismen
dc.subject.otherLipid Metabolismen
dc.subject.otherLipids.blooden
dc.subject.otherRetina.metabolism.pathologyen
dc.titleSevere combined hyperlipidaemia and retinal lipid infiltration in a patient with Type 2 diabetes mellitus.en
dc.typeJournal Articleen
dc.identifier.journaltitleLipids in health and diseaseen
dc.identifier.affiliationDepartment of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australiaen
dc.identifier.doi10.1186/1476-511X-5-29en
dc.description.pages29en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/17173705en
dc.type.austinJournal Articleen
local.name.researcherTebbutt, Niall C
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.grantfulltextopen-
item.fulltextWith Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.languageiso639-1en-
crisitem.author.deptMedical Oncology-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
crisitem.author.deptEndocrinology-
crisitem.author.deptMedicine (University of Melbourne)-
Appears in Collections:Journal articles
Files in This Item:
File Description SizeFormat 
17173705.pdf238.76 kBAdobe PDFThumbnail
View/Open
Show simple item record

Page view(s)

46
checked on Nov 24, 2024

Download(s)

86
checked on Nov 24, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.